LGT Financial Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
DKCM
AAM
TAL
UOC
LGT Financial Advisors's AMED Position: Q1 2025 in Review
LGT Financial Advisors sold out of Amedisys (AMED) in Q1 2025, closing a stake of 43 shares — an estimated $3.9K sold.
LGT Financial Advisors first reported a position in AMED in Q3 2023 and held it in 6 quarters. The position peaked at $8.76K in Q1 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.
- LGT Financial Advisors reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
- LGT Financial Advisors sold 43 Amedisys shares in Q1 2025, an estimated $3.9K.
- LGT Financial Advisors first reported a position in Amedisys in Q3 2023 and held it in 6 quarters.
- LGT Financial Advisors's Amedisys position peaked at $8.76K in Q1 2024.
- 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.
Based on LGT Financial Advisors's 13F filing for Q1 2025, filed 8 May 2025.